• Something wrong with this record ?

Development of N-(4-(1H-Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of β-Catenin with Enhanced Antitumor Activity and Metabolic Stability

M. Puxeddu, L. Ling, S. Ripa, M. D'Ambrosio, M. Nalli, A. Parisi, P. Sciò, A. Coluccia, A. Granese, M. Santelli, D. Masci, P. Cuřínová, C. Naro, C. Sette, A. Pastore, M. Stornaiuolo, C. Bigogno, G. Dondio, L. Di Magno, G. Canettieri, T. Liu, R....

. 2024 ; 67 (22) : 20298-20314. [pub] 20241107

Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc25003370

The potential as a cancer therapeutic target of the recently reported hotspot binding region close to Lys508 of the β-catenin armadillo repeat domain was not exhaustively explored. In order to get more insight, we synthesized novel N-(heterocyclylphenyl)benzenesulfonamides 6-28. The new compounds significantly inhibited Wnt-dependent transcription as well as SW480 and HCT116 cancer cell proliferation. Compound 25 showed binding mode consistent with this hotspot binding region. Compound 25 inhibited the growth of SW480 and HCT116 cancer cells with IC50's of 2 and 0.12 μM, respectively, and was superior to the reference compounds 5 and 5-FU. 25 inhibited the growth of HCT-116 xenografted in BALB/Cnu/nu mice, reduced the expression of the proliferation marker Ki67, and significantly affected the expression of cancer-related genes. After incubation with human and mouse liver microsomes, 25 showed a higher metabolic stability than 5. Compound 25 aims to be a promising lead for the development of colorectal cancer anticancer therapies.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003370
003      
CZ-PrNML
005      
20250206104311.0
007      
ta
008      
250121s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1021/acs.jmedchem.4c01708 $2 doi
035    __
$a (PubMed)39508273
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Puxeddu, Michela $u Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Drug Chemistry and Technologies, Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185 Rome, Italy $1 https://orcid.org/000000020024596X
245    10
$a Development of N-(4-(1H-Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of β-Catenin with Enhanced Antitumor Activity and Metabolic Stability / $c M. Puxeddu, L. Ling, S. Ripa, M. D'Ambrosio, M. Nalli, A. Parisi, P. Sciò, A. Coluccia, A. Granese, M. Santelli, D. Masci, P. Cuřínová, C. Naro, C. Sette, A. Pastore, M. Stornaiuolo, C. Bigogno, G. Dondio, L. Di Magno, G. Canettieri, T. Liu, R. Silvestri, G. La Regina
520    9_
$a The potential as a cancer therapeutic target of the recently reported hotspot binding region close to Lys508 of the β-catenin armadillo repeat domain was not exhaustively explored. In order to get more insight, we synthesized novel N-(heterocyclylphenyl)benzenesulfonamides 6-28. The new compounds significantly inhibited Wnt-dependent transcription as well as SW480 and HCT116 cancer cell proliferation. Compound 25 showed binding mode consistent with this hotspot binding region. Compound 25 inhibited the growth of SW480 and HCT116 cancer cells with IC50's of 2 and 0.12 μM, respectively, and was superior to the reference compounds 5 and 5-FU. 25 inhibited the growth of HCT-116 xenografted in BALB/Cnu/nu mice, reduced the expression of the proliferation marker Ki67, and significantly affected the expression of cancer-related genes. After incubation with human and mouse liver microsomes, 25 showed a higher metabolic stability than 5. Compound 25 aims to be a promising lead for the development of colorectal cancer anticancer therapies.
650    _2
$a lidé $7 D006801
650    _2
$a zvířata $7 D000818
650    12
$a protinádorové látky $x farmakologie $x chemická syntéza $x chemie $7 D000970
650    12
$a beta-katenin $x metabolismus $x antagonisté a inhibitory $7 D051176
650    12
$a sulfonamidy $x farmakologie $x chemie $x chemická syntéza $7 D013449
650    _2
$a myši $7 D051379
650    12
$a proliferace buněk $x účinky léků $7 D049109
650    12
$a myši inbrední BALB C $7 D008807
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a myši nahé $7 D008819
650    _2
$a xenogenní modely - testy protinádorové aktivity $7 D023041
650    _2
$a jaterní mikrozomy $x metabolismus $7 D008862
650    _2
$a HCT116 buňky $7 D045325
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ling, Lele $u Department of Acupuncture and Moxibustion, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, 200086 Shanghai, China
700    1_
$a Ripa, Silvia $u Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 291, 00161 Rome, Italy
700    1_
$a D'Ambrosio, Michele $u Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Drug Chemistry and Technologies, Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185 Rome, Italy
700    1_
$a Nalli, Marianna $u Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Drug Chemistry and Technologies, Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185 Rome, Italy
700    1_
$a Parisi, Anastasia $u Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Drug Chemistry and Technologies, Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185 Rome, Italy
700    1_
$a Sciò, Pietro $u Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Drug Chemistry and Technologies, Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185 Rome, Italy
700    1_
$a Coluccia, Antonio $u Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Drug Chemistry and Technologies, Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185 Rome, Italy $1 https://orcid.org/0000000279408206
700    1_
$a Granese, Arianna $u Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Drug Chemistry and Technologies, Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185 Rome, Italy
700    1_
$a Santelli, Martina $u Department of Basic Biotechnological Sciences, Intensivological and Perioperative Clinics, Catholic University of the Sacred Heart, Largo Francesco Vito 1, 00168 Rome, Italy
700    1_
$a Masci, Domiziana $u Department of Basic Biotechnological Sciences, Intensivological and Perioperative Clinics, Catholic University of the Sacred Heart, Largo Francesco Vito 1, 00168 Rome, Italy $1 https://orcid.org/0000000256155111
700    1_
$a Cuřínová, Petra $u Department of Organic Chemistry, University of Chemistry and Technology Prague, Technická 5, 16628 Prague 6, Czech Republic $1 https://orcid.org/0000000182647032
700    1_
$a Naro, Chiara $u Department of Basic Biotechnological Sciences, Intensivological and Perioperative Clinics, Catholic University of the Sacred Heart, Largo Francesco Vito 1, 00168 Rome, Italy $u GSTeP-Organoids Research Core Facility, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy
700    1_
$a Sette, Claudio $u Department of Basic Biotechnological Sciences, Intensivological and Perioperative Clinics, Catholic University of the Sacred Heart, Largo Francesco Vito 1, 00168 Rome, Italy $u GSTeP-Organoids Research Core Facility, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy
700    1_
$a Pastore, Arianna $u Department of Pharmacy, University of Naples "Federico II", Via Domenico Montesano 49, 80131 Naples, Italy
700    1_
$a Stornaiuolo, Mariano $u Department of Pharmacy, University of Naples "Federico II", Via Domenico Montesano 49, 80131 Naples, Italy $1 https://orcid.org/0000000322005083
700    1_
$a Bigogno, Chiara $u Aphad SrL, Via della Resistenza 65, 20090 Buccinasco, Italy
700    1_
$a Dondio, Giulio $u Aphad SrL, Via della Resistenza 65, 20090 Buccinasco, Italy $1 https://orcid.org/0000000150233804
700    1_
$a Di Magno, Laura $u Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 291, 00161 Rome, Italy
700    1_
$a Canettieri, Gianluca $u Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 291, 00161 Rome, Italy
700    1_
$a Liu, Te $u Shanghai Geriatric Institute of Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 365 South Xiangyang Road, 200031 Shanghai, China
700    1_
$a Silvestri, Romano $u Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Drug Chemistry and Technologies, Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185 Rome, Italy $1 https://orcid.org/0000000324890178
700    1_
$a La Regina, Giuseppe $u Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Drug Chemistry and Technologies, Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185 Rome, Italy $1 https://orcid.org/0000000332521161
773    0_
$w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 67, č. 22 (2024), s. 20298-20314
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39508273 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104307 $b ABA008
999    __
$a ok $b bmc $g 2263258 $s 1239377
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 67 $c 22 $d 20298-20314 $e 20241107 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
LZP    __
$a Pubmed-20250121

Find record

Citation metrics

Archiving options